Both in Biotechnology
Cognition Therapeutics vs MiNK Therapeutics
Over the past year CGTX returned −59.2% and INKT returned −21.1%; their daily moves had a correlation of 0.01.
CGTX −59.2% INKT −21.1%Growth of $1, one year, split-adjusted
| Metric | CGTX | INKT |
|---|---|---|
| Price | $0.6405 | $10.10 |
| Market cap | $60.9M | $51.6M |
| Today | −6.26% | −4.70% |
| 1 month | −31.6% | −11.5% |
| 6 months | −44.8% | −9.7% |
| Year to date | −52.6% | −9.4% |
| 1 year | −59.2% | −21.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $34.0M | $8.8M |
| Dividend yield | — | — |
| Volatility (60d) | 48.8% | 51.8% |
| Short % of float | 8.3% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).